Asimov Company

Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
Industry: Data processing
Headquarters: Boston, Massachusetts, United States
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 30000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-01-01
Last Funding Type: Series A

Visit Website
hello@asimov.com
https://twitter.com/asimovbio
Register and Claim Ownership